Sigma Healthcare Limited
SIG
Rangering i aksjer
#1028
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aksjekurs
$2.00
Markedsverdi
$22.96B
Endring (1 dag)
0.53%
Endring (1 år)
3.13%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Kategori
Healthcare
P/S-forhold for Sigma Healthcare Limited (SIG)
P/S-forhold per October 2026 TTM: 2.99
Ifølge Sigma Healthcare Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 2.99. Ved slutten av 2024 hadde selskapet et P/S-forhold på 0.32.
P/S-historikk for Sigma Healthcare Limited fra 2001 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.99 | 224.91% |
| 2025 | 0.92 | 190.21% |
| 2024 | 0.32 | 102.29% |
| 2023 | 0.16 | 33.16% |
| 2022 | 0.12 | -34.06% |
| 2021 | 0.18 | 8.04% |
| 2020 | 0.17 | 35.77% |
| 2019 | 0.12 | -39.38% |
| 2018 | 0.20 | -22.92% |
| 2017 | 0.26 | 15.54% |
| 2016 | 0.23 | -8.80% |
| 2015 | 0.25 | 29.84% |
| 2014 | 0.19 | -38.78% |
| 2013 | 0.31 | 41.21% |
| 2012 | 0.22 | 37.27% |
| 2011 | 0.16 | -34.35% |
| 2010 | 0.24 | -52.50% |
| 2009 | 0.52 | -22.64% |
| 2008 | 0.67 | -48.44% |
| 2007 | 1.29 | -23.81% |
| 2006 | 1.70 | -86.50% |
| 2004 | 12.56 | -21.73% |
| 2003 | 16.05 | -5.84% |
| 2002 | 17.05 | -44.42% |
| 2001 | 30.67 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 0.28 | -90.73% |
US
|
|
| - | - |
US
|
|
| 0.23 | -92.45% |
US
|
|
| - | - |
US
|
|
| 0.70 | -76.55% |
US
|
